| Allison Flaherty, | |
|
7175 Saltsburg Rd, Pittsburgh, PA 15235-2252 | |
| (412) 795-7366 | |
| (412) 795-6096 |
| Full Name | Allison Flaherty |
|---|---|
| Gender | Female |
| Speciality | Family Practice |
| Experience | 14 Years |
| Location | 7175 Saltsburg Rd, Pittsburgh, Pennsylvania |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1134430937 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207Q00000X | Family Medicine | OS017125 (Pennsylvania) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Upmc St Margaret | Pittsburgh, PA | Hospital |
| Upmc Presbyterian Shadyside | Pittsburgh, PA | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Upmc Community Medicine Inc | 2062318975 | 690 |
News Archive
It is now shockingly clear that poor health is a much broader and deeper problem than past studies have suggested. An authoritative report issued by the Institute of Medicine this week found that, on average, Americans experience higher rates of disease and injury and die sooner than people in other high-income countries.
Amylin Pharmaceuticals, Inc., Eli Lilly and Company and Alkermes, Inc. today confirmed that the U.S. Food and Drug Administration (FDA) has set a new Prescription Drug User Fee Act (PDUFA) action date of March 12 for its review of the exenatide once weekly new drug application (NDA).
StemCells, Inc. announced today that is has received authorization from Swissmedic, the Swiss regulatory agency for therapeutic products, to initiate a Phase I/II clinical trial in Switzerland of the Company's proprietary HuCNS-SC® product candidate (purified human neural stem cells) in chronic spinal cord injury. The trial is designed to assess both safety and preliminary efficacy in patients with varying degrees of paralysis who are three to 12 months post-injury, and will progressively enroll patients based upon the severity of injury.
A viral infection in a pregnant woman not only affects her subsequent ability to provide maternal care but can also trigger depression in her offspring, which can then even extend into the next generation as a result of changes to genetic mechanisms in the brain.
› Verified 7 days ago
| Entity Name | Upmc Community Medicine Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1558976092 PECOS PAC ID: 2062318975 Enrollment ID: O20040217000388 |
News Archive
It is now shockingly clear that poor health is a much broader and deeper problem than past studies have suggested. An authoritative report issued by the Institute of Medicine this week found that, on average, Americans experience higher rates of disease and injury and die sooner than people in other high-income countries.
Amylin Pharmaceuticals, Inc., Eli Lilly and Company and Alkermes, Inc. today confirmed that the U.S. Food and Drug Administration (FDA) has set a new Prescription Drug User Fee Act (PDUFA) action date of March 12 for its review of the exenatide once weekly new drug application (NDA).
StemCells, Inc. announced today that is has received authorization from Swissmedic, the Swiss regulatory agency for therapeutic products, to initiate a Phase I/II clinical trial in Switzerland of the Company's proprietary HuCNS-SC® product candidate (purified human neural stem cells) in chronic spinal cord injury. The trial is designed to assess both safety and preliminary efficacy in patients with varying degrees of paralysis who are three to 12 months post-injury, and will progressively enroll patients based upon the severity of injury.
A viral infection in a pregnant woman not only affects her subsequent ability to provide maternal care but can also trigger depression in her offspring, which can then even extend into the next generation as a result of changes to genetic mechanisms in the brain.
› Verified 7 days ago
| Entity Name | University Of Pittsburgh Physicians |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1619935004 PECOS PAC ID: 8729990239 Enrollment ID: O20040308000883 |
News Archive
It is now shockingly clear that poor health is a much broader and deeper problem than past studies have suggested. An authoritative report issued by the Institute of Medicine this week found that, on average, Americans experience higher rates of disease and injury and die sooner than people in other high-income countries.
Amylin Pharmaceuticals, Inc., Eli Lilly and Company and Alkermes, Inc. today confirmed that the U.S. Food and Drug Administration (FDA) has set a new Prescription Drug User Fee Act (PDUFA) action date of March 12 for its review of the exenatide once weekly new drug application (NDA).
StemCells, Inc. announced today that is has received authorization from Swissmedic, the Swiss regulatory agency for therapeutic products, to initiate a Phase I/II clinical trial in Switzerland of the Company's proprietary HuCNS-SC® product candidate (purified human neural stem cells) in chronic spinal cord injury. The trial is designed to assess both safety and preliminary efficacy in patients with varying degrees of paralysis who are three to 12 months post-injury, and will progressively enroll patients based upon the severity of injury.
A viral infection in a pregnant woman not only affects her subsequent ability to provide maternal care but can also trigger depression in her offspring, which can then even extend into the next generation as a result of changes to genetic mechanisms in the brain.
› Verified 7 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Allison Flaherty, 7175 Saltsburg Rd, Pittsburgh, PA 15235-2252 Ph: (412) 795-7366 | Allison Flaherty, 7175 Saltsburg Rd, Pittsburgh, PA 15235-2252 Ph: (412) 795-7366 |
News Archive
It is now shockingly clear that poor health is a much broader and deeper problem than past studies have suggested. An authoritative report issued by the Institute of Medicine this week found that, on average, Americans experience higher rates of disease and injury and die sooner than people in other high-income countries.
Amylin Pharmaceuticals, Inc., Eli Lilly and Company and Alkermes, Inc. today confirmed that the U.S. Food and Drug Administration (FDA) has set a new Prescription Drug User Fee Act (PDUFA) action date of March 12 for its review of the exenatide once weekly new drug application (NDA).
StemCells, Inc. announced today that is has received authorization from Swissmedic, the Swiss regulatory agency for therapeutic products, to initiate a Phase I/II clinical trial in Switzerland of the Company's proprietary HuCNS-SC® product candidate (purified human neural stem cells) in chronic spinal cord injury. The trial is designed to assess both safety and preliminary efficacy in patients with varying degrees of paralysis who are three to 12 months post-injury, and will progressively enroll patients based upon the severity of injury.
A viral infection in a pregnant woman not only affects her subsequent ability to provide maternal care but can also trigger depression in her offspring, which can then even extend into the next generation as a result of changes to genetic mechanisms in the brain.
› Verified 7 days ago
Christian Lima, Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 100 Delafield Rd, Suite 313, Pittsburgh, PA 15215 Phone: 412-781-0400 | |
Brianne Leigh Wehner, D.O. Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 600 Forbes Ave 3rd Floor Gumberg, Pittsburgh, PA 15282 Phone: 412-396-1650 | |
Gorka Murga, Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 2310 Jane St, Pittsburgh, PA 15203 Phone: 412-586-1755 | |
Bruce Richard Kelly, MD Family Medicine Medicare: Not Enrolled in Medicare Practice Location: 320 Guys Run Road, Pittsburgh, PA 15238 Phone: 412-435-0005 Fax: 412-435-0003 | |
Dr. John Joseph Danek, D.O. Family Medicine Medicare: Not Enrolled in Medicare Practice Location: 575 Coal Valley Road, Suite 502, Jefferson Regional Medical Center, Pittsburgh, PA 15236 Phone: 412-469-5983 Fax: 412-469-5946 | |
Dr. William E Chelen, M.D. Family Medicine Medicare: Not Enrolled in Medicare Practice Location: 120 Marion St., Pittsburgh, PA 15219 Phone: 412-232-3555 | |
Valerie Wislo, Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 7175 Saltsburg Rd, Pittsburgh, PA 15235 Phone: 412-795-7366 |